Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-22
DOI
10.1007/s00125-021-05638-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes
- (2021) Zhongsu Wang et al. MEDICINE
- Gender differences in variables associated with dipeptidyl peptidase 4 genetic polymorphisms in coronary artery disease
- (2020) Shih-Min Chiang et al. Advances in Clinical and Experimental Medicine
- Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats
- (2019) Benedikt A Aulinger et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
- (2017) Yan Zheng et al. Nature Reviews Endocrinology
- DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity
- (2017) Anja Böhm et al. PLoS One
- Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
- (2017) Christian Baumeier et al. Molecular Metabolism
- Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives
- (2016) Tianru Jin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- 2. Classification and Diagnosis of Diabetes
- (2016) DIABETES CARE
- Novel phenotypes of prediabetes?
- (2016) Hans-Ulrich Häring DIABETOLOGIA
- Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals
- (2016) Xiaomin Xing et al. NEUROPEPTIDES
- Phenotypes of prediabetes and stratification of cardiometabolic risk
- (2016) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Dipeptidyl Peptidase-4 Inhibition Ameliorates Western Diet–Induced Hepatic Steatosis and Insulin Resistance Through Hepatic Lipid Remodeling and Modulation of Hepatic Mitochondrial Function
- (2015) Annayya R. Aroor et al. DIABETES
- DPP4 in diabetes
- (2015) Diana Röhrborn Frontiers in Immunology
- Second-generation PLINK: rising to the challenge of larger and richer datasets
- (2015) Christopher C Chang et al. GigaScience
- Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors
- (2014) B. Omar et al. DIABETES
- Incretins or Anti-Incretins? A New Model for the “Entero-Pancreatic Axis”
- (2014) V. Kamvissi et al. HORMONE AND METABOLIC RESEARCH
- Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
- (2014) Anubha Mahajan et al. NATURE GENETICS
- Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
- (2014) Noriyasu Hirasawa et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Adipose Dipeptidyl Peptidase-4 and Obesity: Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
- (2013) H. Sell et al. DIABETES CARE
- The DPP-4 Inhibitor Linagliptin Restores β-Cell Function and Survival in Human Isolated Islets Through GLP-1 Stabilization
- (2013) Payal Shah et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms of the Incretin Effect in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes
- (2013) Andrea Mari et al. PLoS One
- Is there a place for incretin therapies in obesity and prediabetes?
- (2013) Jens Juul Holst et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Five Years of GWAS Discovery
- (2012) Peter M. Visscher et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Direct effect of GLP-1 infusion on endogenous glucose production in humans
- (2012) M. Seghieri et al. DIABETOLOGIA
- Prediabetes: a high-risk state for diabetes development
- (2012) Adam G Tabák et al. LANCET
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
- (2011) D. Lamers et al. DIABETES
- Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
- (2011) Aurélie Waget et al. ENDOCRINOLOGY
- The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes
- (2010) Muhammad A. Abdul-Ghani et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- First diabetes prevalence study in Portugal: PREVADIAB study
- (2010) L. Gardete-Correia et al. DIABETIC MEDICINE
- On the origin of serum CD26 and its altered concentration in cancer patients
- (2009) Oscar J. Cordero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
- (2009) K. Mussig et al. DIABETES
- Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals
- (2008) Luigi Bouchard et al. ACTA DIABETOLOGICA
- GLUCOSE REGULATION OF DIPEPTIDYL PEPTIDASE IV GENE EXPRESSION IS MEDIATED BY HEPATOCYTE NUCLEAR FACTOR-1α IN EPITHELIAL INTESTINAL CELLS
- (2008) Ning Gu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now